Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke

Completed · Phase 1

Conditions studied: Tobacco Use Disorder, Tobacco Dependence, Smoking

In brief

This study will consist of 2 phases. Phase 1 will be a one day crossover study to see the effects of study product on a smoker's desire to smoke, measured by changes in scores on questionnaires given over time. Phase 2 will be a two-week extension, in which subjects will self-administer the study product and visit the study site for assessment of desire to smoke and collection of samples for the evaluation of smoking-related biomarkers.

Key facts

Study ID

NCT01428310

Run by

Rock Creek Pharmaceuticals, Inc.

People needed

109

Starts

2011-09-01

Expected to finish

2011-12-01

Last updated by the study team

2015-10-30

Who can join

Age: 23 and older, up to 72. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy adult smokers
• using at least 1 pack of cigarettes per day, for at least 5 years

You may not qualify if…

• allergy to study product components

Where it is running

• Comfort Inn — Martinsburg, West Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.